INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of INDO US BIOTECH ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of INDO US BIOTECH Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹261.4 Cr | 16% | 6.1% | -48.2% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,033.2 Cr | -0.5% | -6% | -24.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,410.6 Cr | 6.8% | -12.4% | -10.3% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,111.3 Cr | 3.1% | 1% | -12.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹964.3 Cr | 0.4% | -15.9% | -34% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹411.6 Cr | -0.4% | -13.9% | -9.1% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 16% |
6.1% |
-48.2% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses